Comparative analysis of the noncollagenous NC1 domain of type IV collagen: Identification of structural features important for assembly, function, and pathogenesis

Protein Science

Volumn 7, Issue 6, 1998, Pages 1340-1351

  Netzer, Kai Olaf ^a   Suzuki, Ko ^a   Itoh, Yoshifumi ^a   Hudson, Billy G ^a   Khalifah, Raja G ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Basement membrane; Matrix metalloproteinase; NC1; Phylogeny; Secondary structure prediction; Sequence homology; TIMP; Type IV collagen

Indexed keywords

AUTOANTIBODY; COLLAGEN TYPE 4; EPITOPE; GELATIN; GELATINASE A; GLOBULAR PROTEIN; PROTEINASE INHIBITOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ALGORITHM; ALPORT SYNDROME; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GOODPASTURE SYNDROME; HUMAN; MOLECULAR EVOLUTION; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN SECONDARY STRUCTURE;

VERTEBRATA;

EID: 0031745767     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560070610     Document Type: Article

References (63)

1. Allan JA, Docherty AJ, Barker PJ, Huskisson NS, Reynolds JJ, Murphy G. 1995. Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J 309:299-306.
2. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. J Mol Biol 215:403-410.
3. Arnoux B, Merigneau K, Saludjan P, Norris F, Norris K, Bjorn S, Olsen O, Petersen L, Ducruix A. 1995. The 1.6 A structure of Kunitz-type domain from the alpha 3 chain of human type VI collagen. J Mol Biol 246:609-617.
4. Barker DF, Pruchno CJ, Jiang X, Atkin CL, Stone EM, Denison JC, Fain PR, Gregory MC. 1996. A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. Am J Hum Genet 58:1157-1165
5. Birkendal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkendal-Hansen B, DeCarlo A, Engler JA. 1993. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197-250.
6. Blumberg B, MacKrell AJ, Fessler JH. 1988. Drosophila basement membrane procollagen alpha 1(IV). II. Complete cDNA sequence, genomic structure, and general implications for supramolecular assemblies. J Biol Chem 263:18328-18337.
7. Bork P. 1992. Mobile modules and motifs. Curr Opin Struct Biol 2:413-421.
8. Cecchini JP, Knibiehler B, Mirre C, Le Parco Y. 1987. Evidence for a type-IV-related collagen in Drosophila melanogaster. Evolutionary constancy of the carboxyl-terminal noncollagenous domain. Eur J Biochem 165:587-593.
9. Chu ML, Zhang RZ, Pan TC, Stokes D, Conway D, Kuo HJ, Glanville R, Mayer U, Mann K, Deutzmann R, Timpl R. 1990. Mosaic structure of globular domains in the human type VI collagen alpha 3 chain: Similarity to von Willebrand factor, fibronectin, actin, salivary proteins and aprotinin type proteinase inhibitors. EMBO J 9:385-393.
10. Dion AS, Myers JC. 1987. COOH-terminal propeptides of the major human procollagens. Structural, functional and genetic comparisons. J Mol Biol 193:127-143.
11. Dölz R, Engel J, Kuhn K. 1988. Folding of collagen IV. Eur J Biochem 178:357-366.
12. Felsenstein J. 1989. PHYLIP-phylogeny inference package (Version 3.2). Cladistics 5:164-166.
13. Felsenstein J. 1996. Inferring phylogenies from protein sequences by parsimony, distance, and likelihood methods. Methods Enzymol 266:418-427.
14. Gomis-Rüth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W. 1997. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389:77-81.
15. Hobohm U, Sander C. 1995. A sequence property approach to searching protein databases. J Mol Biol 251:390-399.
16. Hudson BG, Reeders ST, Tryggvason K. 1993a. Type IV collagen: Structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 268:26033-26036.
17. Hudson BG, Kalluri R, Gunwar S, Noelken ME, Mariyama M, Reeders ST. 1993b. Molecular characteristics of the Goodpasture autoantigen. Kidney Int 43:135-139.
18. Itoh Y, Binner S, Nagase H. 1995. Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J 308:645-651.
19. Jones DD. 1975. Amino acid properties and side-chain orientation in proteins: A cross correlation approach. J Theor Biol 50:167-183.
20. Kahsai TZ, Enders GC, Gunwar S, Brunmark C, Wieslander J, Kalluri R, Zhou J, Noelken ME, Hudson BG. 1997. Seminiferous tubule basement membrane. Composition and organization of type IV collagen chains, and the linkage of alpha3(IV) and alpha5(IV) chains. J Biol Chem 272:17023-17032.
21. Kalluri R, Gunwar S, Reeders ST, Morrison KC, Mariyama M, Ebner KE, Noelken ME, Hudson BG. 1991. Goodpasture syndrome. Localization of the epitope for the autoantibodies to the carboxyl-terminal region of the alpha 3(IV) chain of basement membrane collagen. J Biol Chem 266:24018-24024.
22. Kalluri R, Sun MJ, Hudson BG, Neilson EG. 1996. The Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen. J Biol Chem 271:9062-9068.
23. Kalluri R, Wilson CB, Weber M, Gunwar S, Chonko AM, Neilson EG, Hudson BG. 1995. Identification of the alpha 3 chain of type IV collagen as the common autoantigen in antibasement membrane disease and Goodpasture syndrome. J Am Soc Nephrol 6:1178-1185.
24. Kefalides NA, Ohno N, Wilson CB, Fillit H, Zabriski J, Rosenbloom J. 1993. Identification of antigenic epitopes in type IV collagen by use of synthetic peptides. Kidney Int 43:94-100.
25. Kimura M. 1980. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol 16:111-120.
26. Knebelmann B, Breillat C, Forestier L, Arrondel C, Jacassier D, Giatras I, Drouot L, Deschenes G, Grunfeld JP, Broyer M, Gubler MC, Antignac C. 1996. Spectrum of mutations in the COL4A5 collagen gene in X-linked Alport syndrome. Am J Hum Genet 59:1221-1232.
27. Knight CG, Willenbrock F, Murphy G. 1992. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix-metalloproteinases. FEBS Lett 296:263-266.
28. Kubota Y, Takahashi S, Nishikawa K, Ooi T. 1981. Homology in protein sequences expressed by correlation coefficients. J Theor Biol 91:347-361.
29. Leinonen A, Mariyama M, Mochizuki T, Tryggvason K, Reeders ST. 1994. Complete primary structure of the human type IV collagen alpha 4(IV) chain. Comparison with structure and expression of the other alpha (IV) chains. J Biol Chem 269:26172-26177.
30. Lemmink HH, Schroeder CH, Brunner HG, Nelen MR, Zhou J, Tryggvason K, Haagsma-Schouten WA, Roodvoets AP, Rascher W, van Oost BA, Smeets HJM. 1993. Identification of four novel mutations in the COL4A5 gene of patients with Alport syndrome. Genomics 17:485-489.
31. Mariyama M, Kalluri R, Hudson BG, Reeders ST. 1992. The alpha 4(IV) chain of basement membrane collagen. Isolation of cDNAs encoding bovine alpha 4(IV) and comparison with other type IV collagens. J Biol Chem 267:1253-1258.
32. Matsukura H, Butkowski RJ, Fish AJ. 1993. The Goodpasture antigen: Common epitopes in the globular domains of collagen IV. Nephron 64:532-539.
33. Monboisse JC, Gamotel R, Bellon G, Ohno N, Perreau C, Borel JP, Kefalides NA. 1994. The alpha 3 chain of type IV collagen prevents activation of human polymorphonuclear leukocytes. J Biol Chem 269:25475-25482.
34. Myers JC, Howard PS, Jelen AM, Dion AS, Macarak EJ. 1987. Duplication of type IV collagen COOH-terminal repeats and species-specific expression of alpha 1(IV) and alpha 2(IV) collagen genes [published erratum appears in J Biol Chem 262(29):14372]. J Biol Chem 262:9231-9238.
35. Nagase H. 1996. Matrix metalloproteinases. In: Hooper, NM, ed. Zinc metalloproteinases in health and disease. London, UK: Taylor & Francis. pp. 153-204.
36. Nagase H, Fields GB. 1996. Human matrix metalloproteinase specificity studies using collagen sequence-based synthetic peptides. Biopolymers 40:339-416.
37. Netzer KO, Seibold S, Gross O, Lambrecht R, Weber M. 1996. Use of psoralen-coupled nucleotide primers for screening of COL4A5 mutations in Alport syndrome. Kidney Int 50:1363-1367.
38. Ninomiya Y, Kagawa M, Iyama K, Naito I, Kishiro Y, Seyer JM, Sugimoto M, Oohashi T, Sado Y. 1995. Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol 130:1219-1229.
39. Oberbäumer I, Laurent M, Schwarz U, Sakurai Y, Yamada Y, Vogeli G, Voss T, Siebold B, Glanville RW, Kuhn K. 1985. Amino acid sequence of the non-collagenous globular domain (NC1) of the alpha 1(IV) chain of basement membrane collagen as derived from complementary DNA. Eur J Biochem 147:217-224.
40. Pearson WR, Lipman DJ. 1988. Improved tools for biological sequence comparison. Proc Natl Acad Sci USA 85:2444-2448.
41. Quinones S, Bernal D, Garcia-Sogo M, Elena SF, Saus J. 1992. Exon/intron structure of the human alpha 3(IV) gene encompassing the Goodpasture antigen (alpha 3(IV)NC1). Identification of a potentially antigenic region at the triple helix/NC1 domain junction. J Biol Chem 267:19780-19784.
42. Renieri A, Bruttini M, Galli L, Zanelli P, Neri T, Rossetti S, Turco A, Heiskari N, Zhou J, Gusmano R, Massella L, Banfi G, Scolari F, Sessa A, Rizzoni G, Tryggvason K, Pignatti PF, Savi M, Ballabio A, De Marchi M. 1996. X-linked Alport syndrome: An SSCP-based mutation survey over all 51 exons of the COL4A5 gene. Am J Hum Genet 58:1192-1204.
43. Ries A, Engel J, Lustig A, Kuhn K. 1995. The function of the NC1 domains in type IV collagen. J Biol Chem 270:23790-23794.
44. Rost B, Sander C. 1993a. Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol 232:584-599.
45. Rost B, Sander C. 1993b. Improved prediction of protein secondary structure by use of sequence profiles and neural networks. Proc Natl Acad Sci USA 90:7558-7562.
46. Saitou N, Nei M. 1987. The neighbor-joining method: A new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406-425.
47. Sander C, Schneider R. 1991. Database of homology derived protein structures and the structural meaning of sequence alignment. Proteins 9:56-68.
48. Saus J, Wieslander J, Langeveld JP, Quinones S, Hudson BG. 1988. Identification of the Goodpasture antigen as the alpha 3(IV) chain of collagen IV. J Biol Chem 263:13374-13380.
49. Siebold B, Deutzmann R, Kühn K. 1988. The arrangement of intra-and intermolecular disulfide bonds in the carboxyterminal, non-collagenous aggregation and cross-linking domain of basement-membrane type IV collagen. Eur J Biochem 176:617-624.
50. Stubbs M, Summers L, Mayr I, Schneider M, Bode W, Huber R, Ries A, Kühn K. 1990. Crystals of the NC1 domain of human type IV collagen. J Mol Biol 211:683-684.
51. Timoneda J, Gunwar S, Monfort G, Saus J, Noelken ME, Hudson BG. 1990. Unusual dissociative behavior of the noncollagenous domain (hexamer) of basement membrane collagen during electrophoresis and chromatofocusing. Conn Tiss Res 24:169-186.
52. Timpl R, Oberbäumer I, von der Mark H, Bode W, Wick G, Weber S, Engel J. 1985. Structure and biology of the globular domain of basement membrane type IV collagen. Ann NY Acad Sci 460:58-72.
53. Tsilibary EC, Charonis AS, Reger LA, Wohlhueter RM, Furcht LT. 1988. The effect of nonenzymatic glucosylation on binding of the main noncollagenous NC1 domain to type IV collagen. J Biol Chem 263:4302-4308.
54. Tverskaya S, Bobrynina V, Tsalykova F, Ignatova M, Krasnopolskaya X, Evgrafov O. 1996. Substitution of A1498D in noncollagen domain of alpha 5(IV) collagen chain associated with adult-onset X-linked Alport syndrome. Hum Mutat 7:149-150.
55. Weber S, Dölz R, Timpl R, Fessler JH, Engel J. 1988. Reductive cleavage and reformation of the interchain and intrachain disulfide bonds in the globular hexameric domain NC1 involved in network assembly of basement membrane collagen (type IV). Eur J Biochem 175:229-236.
56. Weber S, Engel J, Wiedermann H, Glanville RW, Timpl R. 1984. Subunit structure and assembly of the globular domain of basement-membrane collagen type IV. Eur J Biochem 139:401-410.
57. Wieslander J, Bygren P, Heinegard D. 1984. Isolation of the specific glomerular basement membrane antigen involved in Goodpasture syndrome. Proc Natl Acad Sci U.S.A. 81:1544-1548.
58. Wieslander J, Langeveld J, Butkowski R, Jodlowski M, Noelken M, Hudson BG. 1985. Physical and immunochemical studies of the globular domain of type IV collagen. Cryptic properties of the Goodpasture antigen. J Biol Chem 260:8564-8570.
59. Williamson RA, Martorell G, Carr MD, Murphy G, Docherty AJ, Freedman RB, Feeney J. 1994. Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry 33:11745-11759.
60. Zhou J, Barker DF, Hostikka SL, Gregory MC, Atkin CL, Tryggvason K. 1991. Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. Genomics 9:10-18.
61. Zhou J, Ding M, Zhao Z, Reeders ST. 1994. Complete primary structure of the sixth chain of human basement membrane collagen, alpha 6(IV). Isolation of the cDNAs for alpha 6(IV) and comparison with five other type IV collagen chains. J Biol Chem 269:13193-13199.
62. Zhou J, Gregory MC, Hertz JM, Barker DF, Atkin C, Spencer ES, Tryggvason K. 1993. Mutations in the codon for a conserved arginine-1563 in the COL4A5 collagen gene in Alport syndrome. Kidney Int 43:722-729.
63. Zimmerman JM, Eliezer N, Simha R. 1968. The characterization of amino acid sequences in proteins by statistical methods. J Theor Biol 21:170-201.